Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997. (2018)

First Author: Delles C
Attributed to:  Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ejhf.1076

PubMed Identifier: 29226610

Publication URI: http://europepmc.org/abstract/MED/29226610

Type: Journal Article/Review

Volume: 20

Parent Publication: European journal of heart failure

Issue: 4

ISSN: 1388-9842